Literature DB >> 20452985

Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif.

Lisa-Marie Munter1, Anne Botev, Luise Richter, Peter W Hildebrand, Veit Althoff, Christoph Weise, Daniela Kaden, Gerd Multhaup.   

Abstract

The identification of hereditary familial Alzheimer disease (FAD) mutations in the amyloid precursor protein (APP) and presenilin-1 (PS1) corroborated the causative role of amyloid-beta peptides with 42 amino acid residues (Abeta42) in the pathogenesis of AD. Although most FAD mutations are known to increase Abeta42 levels, mutations within the APP GxxxG motif are known to lower Abeta42 levels by attenuating transmembrane sequence dimerization. Here, we show that aberrant Abeta42 levels of FAD mutations can be rescued by GxxxG mutations. The combination of the APP-GxxxG mutation G33A with APP-FAD mutations yielded a constant 60% decrease of Abeta42 levels and a concomitant 3-fold increase of Abeta38 levels compared with the Gly(33) wild-type as determined by ELISA. In the presence of PS1-FAD mutations, the effects of G33A were attenuated, apparently attributable to a different mechanism of PS1-FAD mutants compared with APP-FAD mutants. Our results contribute to a general understanding of the mechanism how APP is processed by the gamma-secretase module and strongly emphasize the potential of the GxxxG motif in the prevention of sporadic AD as well as FAD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452985      PMCID: PMC2898405          DOI: 10.1074/jbc.M109.088005

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Novel Leu723Pro amyloid precursor protein mutation increases amyloid beta42(43) peptide levels and induces apoptosis.

Authors:  J B Kwok; Q X Li; M Hallupp; S Whyte; D Ames; K Beyreuther; C L Masters; P R Schofield
Journal:  Ann Neurol       Date:  2000-02       Impact factor: 10.422

Review 2.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

3.  Equimolar production of amyloid beta-protein and amyloid precursor protein intracellular domain from beta-carboxyl-terminal fragment by gamma-secretase.

Authors:  Nobuto Kakuda; Satoru Funamoto; Sousuke Yagishita; Mako Takami; Satoko Osawa; Naoshi Dohmae; Yasuo Ihara
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

4.  Abeta42 overproduction associated with structural changes in the catalytic pore of gamma-secretase: common effects of Pen-2 N-terminal elongation and fenofibrate.

Authors:  Noriko Isoo; Chihiro Sato; Hiroyuki Miyashita; Mitsuru Shinohara; Nobumasa Takasugi; Yuichi Morohashi; Shoji Tsuji; Taisuke Tomita; Takeshi Iwatsubo
Journal:  J Biol Chem       Date:  2007-02-28       Impact factor: 5.157

Review 5.  The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.

Authors:  John Hardy
Journal:  J Neurochem       Date:  2009-05-18       Impact factor: 5.372

6.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.

Authors:  M C Chartier-Harlin; F Crawford; H Houlden; A Warren; D Hughes; L Fidani; A Goate; M Rossor; P Roques; J Hardy
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

7.  Subcellular localization and dimerization of APLP1 are strikingly different from APP and APLP2.

Authors:  Daniela Kaden; Philipp Voigt; Lisa-Marie Munter; Karolina D Bobowski; Michael Schaefer; Gerd Multhaup
Journal:  J Cell Sci       Date:  2009-01-06       Impact factor: 5.285

8.  Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein.

Authors:  J Rossjohn; R Cappai; S C Feil; A Henry; W J McKinstry; D Galatis; L Hesse; G Multhaup; K Beyreuther; C L Masters; M W Parker
Journal:  Nat Struct Biol       Date:  1999-04

9.  Early onset familial Alzheimer's disease: Mutation frequency in 31 families.

Authors:  J C Janssen; J A Beck; T A Campbell; A Dickinson; N C Fox; R J Harvey; H Houlden; M N Rossor; J Collinge
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

10.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.

Authors:  R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

View more
  34 in total

1.  On GxxxG in N-terminal stretches of type-1 VDAC/porin: critical in vertebrate apoptosis, missing in plants.

Authors:  Friedrich P Thinnes
Journal:  Plant Mol Biol       Date:  2012-03-27       Impact factor: 4.076

2.  Molecular engineering of a secreted, highly homogeneous, and neurotoxic aβ dimer.

Authors:  Andreas Müller-Schiffmann; Aksana Andreyeva; Anselm H C Horn; Kurt Gottmann; Carsten Korth; Heinrich Sticht
Journal:  ACS Chem Neurosci       Date:  2011-03-11       Impact factor: 4.418

3.  Extension of a protein docking algorithm to membranes and applications to amyloid precursor protein dimerization.

Authors:  Shruthi Viswanath; Laura Dominguez; Leigh S Foster; John E Straub; Ron Elber
Journal:  Proteins       Date:  2015-10-14

4.  Familial Alzheimer's mutations within APPTM increase Aβ42 production by enhancing accessibility of ε-cleavage site.

Authors:  Wen Chen; Eric Gamache; David J Rosenman; Jian Xie; Maria M Lopez; Yue-Ming Li; Chunyu Wang
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

5.  The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication.

Authors:  Ulrike K Resenberger; Anja Harmeier; Andreas C Woerner; Jessica L Goodman; Veronika Müller; Rajaraman Krishnan; R Martin Vabulas; Hans A Kretzschmar; Susan Lindquist; F Ulrich Hartl; Gerd Multhaup; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  EMBO J       Date:  2011-03-25       Impact factor: 11.598

6.  Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization.

Authors:  Luise Richter; Lisa-Marie Munter; Julia Ness; Peter W Hildebrand; Muralidhar Dasari; Stephanie Unterreitmeier; Bruno Bulic; Michael Beyermann; Ronald Gust; Bernd Reif; Sascha Weggen; Dieter Langosch; Gerd Multhaup
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

7.  Lowering of amyloid beta peptide production with a small molecule inhibitor of amyloid-β precursor protein dimerization.

Authors:  Pauline Pl So; Ella Zeldich; Kathleen I Seyb; Mickey M Huang; John B Concannon; Gwendalyn D King; Ci-Di Chen; Gregory D Cuny; Marcie A Glicksman; Carmela R Abraham
Journal:  Am J Neurodegener Dis       Date:  2012

Review 8.  Amyloid Precursor Protein (APP) Metabolites APP Intracellular Fragment (AICD), Aβ42, and Tau in Nuclear Roles.

Authors:  Gerhard Multhaup; Otmar Huber; Luc Buée; Marie-Christine Galas
Journal:  J Biol Chem       Date:  2015-08-21       Impact factor: 5.157

9.  Conformational changes induced by the A21G Flemish mutation in the amyloid precursor protein lead to increased Aβ production.

Authors:  Tzu-Chun Tang; Yi Hu; Pascal Kienlen-Campard; Laetitia El Haylani; Marie Decock; Joanne Van Hees; Ziao Fu; Jean-Noel Octave; Stefan N Constantinescu; Steven O Smith
Journal:  Structure       Date:  2014-01-23       Impact factor: 5.006

10.  Side-chain to main-chain hydrogen bonding controls the intrinsic backbone dynamics of the amyloid precursor protein transmembrane helix.

Authors:  Christina Scharnagl; Oxana Pester; Philipp Hornburg; Daniel Hornburg; Alexander Götz; Dieter Langosch
Journal:  Biophys J       Date:  2014-03-18       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.